Roche Holding AG (OTCMKTS:RHHBY) Receives Average Recommendation of "Moderate Buy" from Brokerages

Key Points

• Roche Holding AG has received a consensus recommendation of "Moderate Buy" from seven brokerages, with varying ratings including one sell, three holds, one buy, and two strong buys.
• HSBC Global Research has downgraded Roche's stock rating from "strong-buy" to "hold," reflecting a change in their outlook on the company's performance.
• Shares of Roche opened at $38.62, with a 1-year low of $34.10 and a high of $44.31, indicating volatility in its stock price over the past year.

Shares of Roche Holding AG (OTCMKTS:RHHBY - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the seven ratings firms that are currently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation, one has assigned a buy recommendation and two have issued a strong buy recommendation on the company.

A number of equities analysts recently weighed in on RHHBY shares. Hsbc Global Res lowered shares of Roche from a "strong-buy" rating to a "hold" rating in a research report on Monday, April 28th. HSBC lowered shares of Roche from a "buy" rating to a "hold" rating in a research report on Monday, April 28th.

Roche Price Performance

Shares of OTCMKTS RHHBY opened at $38.62 on Friday. The firm has a fifty day moving average price of $40.33 and a 200-day moving average price of $40.24. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.48 and a quick ratio of 1.20. Roche has a 1 year low of $34.10 and a 1 year high of $44.31.

Hedge Funds Weigh In On Roche

Several institutional investors have recently bought and sold shares of the business. First Horizon Advisors Inc. lifted its position in Roche by 81.2% during the second quarter. First Horizon Advisors Inc. now owns 1,843 shares of the company's stock valued at $75,000 after purchasing an additional 826 shares during the last quarter. Verity Asset Management Inc. lifted its holdings in shares of Roche by 12.5% in the 2nd quarter. Verity Asset Management Inc. now owns 9,092 shares of the company's stock worth $371,000 after acquiring an additional 1,008 shares during the last quarter. Yousif Capital Management LLC lifted its holdings in shares of Roche by 7.8% in the 2nd quarter. Yousif Capital Management LLC now owns 88,547 shares of the company's stock worth $3,593,000 after acquiring an additional 6,395 shares during the last quarter. OLD National Bancorp IN lifted its holdings in shares of Roche by 2.9% in the 2nd quarter. OLD National Bancorp IN now owns 261,317 shares of the company's stock worth $10,604,000 after acquiring an additional 7,326 shares during the last quarter. Finally, Boston Common Asset Management LLC lifted its holdings in shares of Roche by 11.1% in the 2nd quarter. Boston Common Asset Management LLC now owns 361,833 shares of the company's stock worth $14,682,000 after acquiring an additional 36,101 shares during the last quarter.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.